Biliary atresia (BA) represents the most frequent indication for liver transplantation (OLTX) in the pediatric population. The aim of this paper was to present a series collected over the last 7 years from October 1997 through July 2004, including 260 pediatric OLTX in 231 patients. BA was the indication in 137 patients. There were 69 boys and 68 girls of mean weight 10.68 kg and median age 0.9 years. As a primary transplant, 99 patients received a LLS graft; 27 a whole graft; four a I+IV-VIII segment, and two a I-IV segment. Mean follow up was 1047 days (range, 1-2496 day). Infections were diagnosed in 45 patients, vascular complications in 27 patients. Surgical complications that required reintervention occurred in 25 patients. In 41 cases biliary complications occurred, 11 requiring reintervention. 16 patients were retransplanted. In two cases another re-OLTx was performed. Currently 126 patients are alive, showing an actuarial 1 year survival of 92% and 5 year 91%, with actuarial graft survivals of 85% at 1 year and 82% at 3 and 5 years. Our results confirm the effectiveness of OLTx for the treatment of children with BA and a failed Kasai procedure. Split liver grafts represent an excellent organ supply for these patients, achieving optimal results with no mortality on the waiting list.

Colledan, M., Torri, E., Bertani, A., Corno, V., Guizzetti, M., Lucianetti, A., et al. (2005). Orthotopic liver transplantation for biliary atresia. TRANSPLANTATION PROCEEDINGS, 37(2), 1153-1154 [10.1016/j.transproceed.2004.11.031].

Orthotopic liver transplantation for biliary atresia

Colledan M;
2005

Abstract

Biliary atresia (BA) represents the most frequent indication for liver transplantation (OLTX) in the pediatric population. The aim of this paper was to present a series collected over the last 7 years from October 1997 through July 2004, including 260 pediatric OLTX in 231 patients. BA was the indication in 137 patients. There were 69 boys and 68 girls of mean weight 10.68 kg and median age 0.9 years. As a primary transplant, 99 patients received a LLS graft; 27 a whole graft; four a I+IV-VIII segment, and two a I-IV segment. Mean follow up was 1047 days (range, 1-2496 day). Infections were diagnosed in 45 patients, vascular complications in 27 patients. Surgical complications that required reintervention occurred in 25 patients. In 41 cases biliary complications occurred, 11 requiring reintervention. 16 patients were retransplanted. In two cases another re-OLTx was performed. Currently 126 patients are alive, showing an actuarial 1 year survival of 92% and 5 year 91%, with actuarial graft survivals of 85% at 1 year and 82% at 3 and 5 years. Our results confirm the effectiveness of OLTx for the treatment of children with BA and a failed Kasai procedure. Split liver grafts represent an excellent organ supply for these patients, achieving optimal results with no mortality on the waiting list.
Articolo in rivista - Articolo scientifico
abdominal infection; acute graft rejection; adolescent; adult; anastomosis dehiscence; artery thrombosis; ascites; bile duct atresia; bile duct fistula; bile duct obstruction; body weight; cardiovascular disease; cava vein; child; cholangitis; chronic graft rejection; chylothorax; conference paper; enteritis; evisceration; female; follow up; gastrointestinal hemorrhage; graft survival; hemoperitoneum; hepatic artery; human; intestine obstruction; intestine perforation; liver graft; liver graft rejection; lung infection; major clinical study; male; multiple organ failure; pleura effusion; portal vein obstruction; portal vein thrombosis; portoenterostomy; postoperative complication; postoperative hemorrhage; postoperative thrombosis; priority journal; reoperation; sepsis; surgical infection; surgical mortality; survival rate; survival time; treatment failure;
English
2005
37
2
1153
1154
reserved
Colledan, M., Torri, E., Bertani, A., Corno, V., Guizzetti, M., Lucianetti, A., et al. (2005). Orthotopic liver transplantation for biliary atresia. TRANSPLANTATION PROCEEDINGS, 37(2), 1153-1154 [10.1016/j.transproceed.2004.11.031].
File in questo prodotto:
File Dimensione Formato  
Transp proc 2005 atresiaf.pdf

Solo gestori archivio

Dimensione 48.5 kB
Formato Adobe PDF
48.5 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10281/365654
Citazioni
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 3
Social impact